Examine impressive results for simple, uncomplicated clot prevention
See study designs and results for the rivaroxaban phase III studies
View the direct inhibition of Factor Xa, an active area of research
Thromboembolic disorders pose life threatening risks to millions of patients
Connect with a world of events devoted to thromboembolic research
Learn more about ‘Xarelto’ and Thrombosis by watching videos and using interactive tools
Your e-mail address will neither be stored nor used for any other purpose than providing you the requested documents.
20/11/2012
16/06/2009
08/05/2008
